Stock
Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned
US listed securityListed on NASDAQ
US headquarteredHeadquartered in Foster City, California, United States
Follow
Gilead Sciences, Inc.
$62.75
GILD
After Hours:(0.24%)+$0.15
$62.90
Closed: Mar 3, 7:59:48 PM GMT-5 · USD · NASDAQ · Disclaimer
In the news
Financial performance
| (USD) | Q4 2020 | Year/year change |
|---|---|---|
Revenue | 7.42B | 26.23% |
Net income | 1.55B | -42.47% |
| Diluted EPS | 1.24 | -41.78% |
| Net profit margin | 20.90% | -54.43% |
| Operating income | 3.92B | 106.87% |
| Net change in cash | -6.89B | -419.38% |
| Cash on hand | 6.00B | -48.44% |
| Cost of revenue | 517.00M | -69.28% |
About
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500. Wikipedia
CEO
Founded
Jun 22, 1987
Website
Employees
13,600
Key stats
Previous close
The last closing price
$63.01
Day range
The difference between the high and low prices over the past day
$62.17 - $63.32
Year range
The difference between the high and low prices over the past 52 weeks
$56.56 - $85.97
Market cap
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
78.85B USD
Volume
The average number of shares traded each day over the past 30 days
8.25M
P/E ratio
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
644.32
Dividend yield
The ratio of annual dividend to current share price that estimates the dividend return of a stock
4.53%
CDP Climate Change Score
A score provided by CDP (formerly the Carbon Disclosure Project) that rates a company on its climate transparency and performance
Primary exchange
Listed exchange for this security
NASDAQ
About
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500. Wikipedia
CEO
Founded
Jun 22, 1987
Website
Employees
13,600
